Home Healthcare Pharmaceuticals Gastroparesis Drugs Market

Gastroparesis Drugs Market Size, Share & Trends Analysis Report By Drug Class (Prokinetic Agents, Antiemetic Agents, Botulinum Toxin Injections), By Disease Type (Diabetic Gastroparesis, Idiopathic Gastroparesis, Post-surgical Gastroparesis, Others), By End-User (Hospitals, Pharmacies, Clinics) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR5870DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Gastroparesis Drugs Market Size Analysis
    1. Introduction
    2. Gastroparesis Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Prokinetic Agents
      2. Antiemetic Agents
      3. Botulinum Toxin Injections
    3. Gastroparesis Drugs Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Diabetic Gastroparesis
      2. Idiopathic Gastroparesis
      3. Post-surgical Gastroparesis
      4. Others
    4. Gastroparesis Drugs Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Pharmacies
      3. Clinics
  7. North America Gastroparesis Drugs Market Size Analysis
    1. Introduction
    2. Gastroparesis Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Prokinetic Agents
      2. Antiemetic Agents
      3. Botulinum Toxin Injections
    3. Gastroparesis Drugs Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Diabetic Gastroparesis
      2. Idiopathic Gastroparesis
      3. Post-surgical Gastroparesis
      4. Others
    4. Gastroparesis Drugs Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Pharmacies
      3. Clinics
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
  8. Europe Gastroparesis Drugs Market Size Analysis
    1. Introduction
    2. Gastroparesis Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Prokinetic Agents
      2. Antiemetic Agents
      3. Botulinum Toxin Injections
    3. Gastroparesis Drugs Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Diabetic Gastroparesis
      2. Idiopathic Gastroparesis
      3. Post-surgical Gastroparesis
      4. Others
    4. Gastroparesis Drugs Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Pharmacies
      3. Clinics
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    7. France
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
  9. APAC Gastroparesis Drugs Market Size Analysis
    1. Introduction
    2. Gastroparesis Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Prokinetic Agents
      2. Antiemetic Agents
      3. Botulinum Toxin Injections
    3. Gastroparesis Drugs Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Diabetic Gastroparesis
      2. Idiopathic Gastroparesis
      3. Post-surgical Gastroparesis
      4. Others
    4. Gastroparesis Drugs Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Pharmacies
      3. Clinics
    5. China
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    8. India
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    10. Singapore
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
  10. Middle East and Africa Gastroparesis Drugs Market Size Analysis
    1. Introduction
    2. Gastroparesis Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Prokinetic Agents
      2. Antiemetic Agents
      3. Botulinum Toxin Injections
    3. Gastroparesis Drugs Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Diabetic Gastroparesis
      2. Idiopathic Gastroparesis
      3. Post-surgical Gastroparesis
      4. Others
    4. Gastroparesis Drugs Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Pharmacies
      3. Clinics
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
  11. LATAM Gastroparesis Drugs Market Size Analysis
    1. Introduction
    2. Gastroparesis Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Prokinetic Agents
      2. Antiemetic Agents
      3. Botulinum Toxin Injections
    3. Gastroparesis Drugs Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Diabetic Gastroparesis
      2. Idiopathic Gastroparesis
      3. Post-surgical Gastroparesis
      4. Others
    4. Gastroparesis Drugs Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Pharmacies
      3. Clinics
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Prokinetic Agents
        2. Antiemetic Agents
        3. Botulinum Toxin Injections
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Diabetic Gastroparesis
        2. Idiopathic Gastroparesis
        3. Post-surgical Gastroparesis
        4. Others
      4. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmacies
        3. Clinics
  12. Competitive Landscape
    1. Gastroparesis Drugs Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. AbbVie Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Aclipse Therapeutics
    3. ANI Pharmaceuticals Inc.
    4. Bausch Health Companies Inc.
    5. Cadila Pharmaceuticals Ltd.
    6. Eisai Co. Ltd.
    7. Evoke Pharma Inc.
    8. GlaxoSmithKline Plc
    9. Ipca Laboratories Ltd.
    10. Johnson and Johnson
    11. Medtronic Plc
    12. Otsuka Pharmaceutical Co. Ltd.
    13. Pfizer Inc.
    14. Processa Pharmaceuticals Inc.
    15. Rhythm Pharmaceuticals Inc.
    16. Takeda Pharmaceutical Co. Ltd.
    17. Theravance Biopharma Inc.
    18. Vanda Pharmaceuticals Inc.
    19. Neurogastrx Inc.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.